Results 111 to 120 of about 870,683 (269)
Arthritis Care &Research, EarlyView.Objective Systemic lupus erythematosus (SLE) is a heterogenous inflammatory condition with widely varying global prevalence estimates. The frequency of SLE in the general population of Australia has been reported to be notably lower than contemporary estimates in countries such as the United States or United Kingdom, at 19 to 39 per 100,000 as opposed ...
Lucinda Roper +7 more
wiley +1 more source
Arthritis Care &Research, EarlyView.Objective We aimed to estimate the prevalence and cumulative incidence of hydroxychloroquine retinopathy (HCQ‐R) and its risk factors among patients receiving long‐term HCQ with rheumatic diseases through a systematic review and meta‐analysis of observational studies that used spectral‐domain optical coherence tomography (SD‐OCT) for screening ...
Narsis Daftarian +4 more
wiley +1 more source
Arthritis Care &Research, EarlyView.Objective Clinical response to mycophenolic acid (MPA) is highly heterogeneous; thus, therapeutic drug level monitoring (TDM) may help improve treatment efficacy. This systematic review and meta‐analysis examined therapeutic ranges for MPA levels associated with better outcomes and safety in patients with systemic lupus erythematosus (SLE ...
Zahraa Qamhieh +5 more
wiley +1 more source
Arthritis Care &Research, EarlyView.People with systemic autoimmune and rheumatic diseases (SARDs) are at higher risk than the general population of experiencing adverse pregnancy and perinatal outcomes such as preeclampsia, intrauterine growth restriction, and maternal and/or fetal death.
Mehret Birru Talabi, Sonya Borrero
wiley +1 more source
Arthritis Care &Research, EarlyView.Objective Hydroxychloroquine (HCQ) is a cornerstone therapy in systemic lupus erythematosus (SLE), but the weight‐based dosing does not account for clinical factors that can introduce individual variability in drug metabolism and clearance. We leveraged longitudinal data from a prospective SLE cohort to identify clinical factors that predict ...
Jay J. Patel +6 more
wiley +1 more source
Patient Preference and AdherenceLiknaw Workie Limenh,1 Tewodros Ayalew Tessema,1 Wudneh Simegn,2 Wondim Ayenew,2 Zemenu Wube Bayleyegn,2 Ashenafi Kibret Sendekie,3 Gashaw Sisay Chanie,3 Eneyew Talie Fenta,4 Alemante Tafese Beyna,5 Asmamaw Emagn Kasahun1 1Department of Pharmaceutics ...
Limenh LW +9 more
doaj
PRM15 ADHERENCE IS ADHERENCE IS ADHERENCE: THE CONSISTENCY OF MORISKY ADHERENCE SCORES ACROSS THE COSTLIEST CHRONIC CONDITIONS [PDF]
Value in Health, 2011 DiBonaventura, M.D. +3 more
openaire +1 more source
Arthritis Care &Research, EarlyView.Objective To evaluate how modifiable psychosocial factors and fatigue relate to physical functioning in patients with systemic lupus erythematosus (SLE). Methods In this cross‐sectional study of two demographically distinct cohorts (Approaches to Positive, Patient‐Centered Experiences of Aging with Lupus [APPEAL] and California Lupus Epidemiology Study
Mrinalini Dey +8 more
wiley +1 more source
Mucolytic Therapy in COPD: Patient Usage and Preferences in Real-World Italian Settings
International Journal of COPDSalvatore D’Antonio,1 Alfio Pennisi,2 Mario Cazzola3 1Italian COPD Patients Association, Rome, Italy; 2Department of Respiratory Medicine, Hospital Clinic ‘Casa di Cura Riabilitativa Calaciura’, Catania, Italy; 3Unit of Respiratory Medicine, Department ...
D'Antonio S, Pennisi A, Cazzola M
doaj